- Home
- / UK & Ireland solutions /
- Pricing Strategy
Pricing strategy
Determining the right pricing strategy is essential to optimise discussions with payers and HTA bodies which in turn accelerates patient access and maximising revenue and accelerate patient access.
Do you want to be:
- The first to market with your innovative products, achieve and maintain first-mover advantage?
- Achieve optimum reimbursement and pricing?
- Launch your products in the UK, Ireland and across Europe?
What we can offer you
In partnership with our clients, we map out successful market access, pricing, and reimbursement strategies. Our teams understand the complexity of today’s Market Access environment and help you navigate it and ultimately accelerate patient access.
Kintiga sees the bigger picture. We help clients avoid common pitfalls and provide timely strategic advice. This results in higher reimbursement success rates and first-mover advantage.
Our services
- Develop pricing strategies based on over 350 clients, and over 540 HTA submissions
- Develop your optimum evidence package by providing early insights and strategy
- Determine best launch sequencing through international reference pricing
- Acquire payer and stakeholder insights into the perceived value of your product
- Understand payer evidence requirements to support reimbursement
- Assess the willingness to pay through payer research
- Maximise commercial access pricing support to enhance reimbursement
Delivering impact through excellence
Results speak louder than words. At Kintiga, our track record of success demonstrates our ability to deliver impactful market access strategies that align with your ambitions.
Let’s have a chat
We pride ourselves to have a personal relationship with our network of stakeholders, opinion leaders and clients, and we would love to get to know you as well. Feel free to reach out for a chat.
Julia Sus
Director, Market Access, UK
Claire Blaney
Director Market Access & Pricing Strategy Ireland
Priscila Mazzola
Director, Head of Value Communication in Value Communication
Ben Hendry
Director, Business Development UK & Ireland
Featured case studies
Delivering a Successful SMC Re‑Submission Through Strategic Alignment and Rapid Cross‑Functional Execution
Faster, Fairer, Broader: What NICE’s 2025–26 Annual Report Means for Market Access
NICE’s New Rulebook for Obesity Health Economics: What PMG50 Means for Modellers
PMI Pharma Summit
NICE Conference 2026
Poster Presentation: Increased trends of self-optimised submissions to NICE (HTA 199)
Our expertise:
UK and Ireland Access Consultancy
Our UK and Ireland team provide tailored strategic guidance and end-to-end support across development, launch, and lifecycle management, aligned with NICE, SMC, AWMSG, and NCPE pathways and evolving HTA expectations.
UK and Ireland Market Access Pathways
Success starts with a clear launch pathway. Kintiga offers UK and Ireland expertise, supporting NICE, SMC, AWMSG, and NCPE submissions with strong evidence alignment, payer negotiation, and stakeholder engagement to drive positive outcomes.
EU HTA Strategy Support
With extensive NICE submission experience, Kintiga is well positioned to support Joint Clinical Assessments, offering integrated solutions from JSC advice to JCA reporting for successful EU HTA outcomes.
Health Economics and Outcomes Research
Our Health Economists build and adapt economic models for the UK and Ireland, integrating local data, comparators, and care pathways. We also develop early pricing and access models to guide investment and evidence strategies aligned with payer expectations.
Pricing Strategy
Kintiga analyses pricing landscapes and benchmarks competitors to shape early pricing strategies. We integrate value messaging and design long-term frameworks like risk-sharing and managed entry agreements to ensure sustainable UK and Ireland market access.
Policy and Systems Navigation
Kintiga monitors policy changes across NHSE, DoH, HSE, and regional bodies to assess their impact on your product. We provide strategic engagement with key institutions and support managed access, conditional reimbursement, and policy initiatives to optimise market entry and sustainability.
Contact us
Ready to unlock your product’s potential in Europe’s complex healthcare landscape? Contact Kintiga today to discover how our market access strategy expertise can drive measurable impact for your product.
